Ariel Halper-Stromberg to HIV-1
This is a "connection" page, showing publications Ariel Halper-Stromberg has written about HIV-1.
Connection Strength
1.566
-
Towards HIV-1 remission: potential roles for broadly neutralizing antibodies. J Clin Invest. 2016 Feb; 126(2):415-23.
Score: 0.492
-
Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice. Cell. 2014 Aug 28; 158(5):989-999.
Score: 0.446
-
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller. Sci Transl Med. 2017 01 18; 9(373).
Score: 0.132
-
Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo. Science. 2016 May 20; 352(6288):1001-4.
Score: 0.126
-
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants. J Exp Med. 2014 Nov 17; 211(12):2361-72.
Score: 0.113
-
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice. Proc Natl Acad Sci U S A. 2013 Oct 08; 110(41):16538-43.
Score: 0.105
-
Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodies. J Exp Med. 2013 Jun 03; 210(6):1235-49.
Score: 0.103
-
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. Proc Natl Acad Sci U S A. 2012 Nov 20; 109(47):E3268-77.
Score: 0.025
-
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice. Nature. 2012 Dec 06; 492(7427):118-22.
Score: 0.025